Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2026-03-19 @ 11:56 AM
Study NCT ID:
NCT00566267
Status:
COMPLETED
Last Update Posted:
2007-12-03
First Post:
2007-11-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized, Double-Blinded Study of Simvastatin 20 mg/Day Versus Vytorin 10/20 in Subjects With Lipid Profiles Not Meeting Current NCEP Guidelines, Following a Low-Carbohydrate Diet
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Organization Data
Organization:
Class:
FED
Study ID:
00887
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Frederick F. Samaha, M.D.
Old Organization:
None